October 18, 2020
The new standard of care for acute myeloid leukaemia
Myeloid Leukaemia (AML) is a rare but intense type of cancer of myeloid cells (white blood cells responsible for strengthening our immune system and fighting infection). The new standard of care for acute myeloid leukaemia is being tested all around the world for effective treatment of its patients. The latest results from the VIALE-A phase III clinical trial from this summer revealed a 34% decrease in the death risk, by









